Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prolonged release pirfenidone pharmacokinetics is modified in cirrhosis GENESIS study.
Poo JL, Aguilar JR, Bernal-Reyes R, Alonso-Campero R, Gasca F, Hernández L, Pineyro-Garza E, Gomez-Silva M, Gamino ME, la Parra MG, Peña P, Hernández N, Tapia G, Muñoz-Espinosa LE. Poo JL, et al. Biomed Pharmacother. 2023 Dec;168:115712. doi: 10.1016/j.biopha.2023.115712. Epub 2023 Oct 21. Biomed Pharmacother. 2023. PMID: 37871556 Free article.
Prolonged-release pirfenidone in patients with pulmonary fibrosis as a phenotype of post-acute sequelae of COVID-19 pneumonia. Safety and efficacy.
Sansores RH, Ramírez-Venegas A, Montiel-Lopez F, Domínguez-Arellano S, Alva-Lopez LF, Falfán-Valencia R, Pérez-Rubio G, Olaya-López E, Zavaleta-Martínez EO, Aguilar-Medina S, Escobar-Alvarado JC, Poo JL, Matera MG, Cazzola M. Sansores RH, et al. Among authors: poo jl. Respir Med. 2023 Oct;217:107362. doi: 10.1016/j.rmed.2023.107362. Epub 2023 Jul 13. Respir Med. 2023. PMID: 37451648 Clinical Trial.
Effect of Prolonged-Release Pirfenidone on Renal Function in Septic Acute Kidney Injury Patients: A Double-Blind Placebo-Controlled Clinical Trial.
Chávez-Iñiguez JS, Poo JL, Ibarra-Estrada M, García-Benavides L, Navarro-Blackaller G, Cervantes-Sánchez C, Nungaray-Pacheco E, Medina-González R, Armendariz-Borunda J, García-García G. Chávez-Iñiguez JS, et al. Among authors: poo jl. Int J Nephrol. 2021 Jan 13;2021:8833278. doi: 10.1155/2021/8833278. eCollection 2021. Int J Nephrol. 2021. PMID: 33520317 Free PMC article.
Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study.
Poo JL, Torre A, Aguilar-Ramírez JR, Cruz M, Mejía-Cuán L, Cerda E, Velázquez A, Patiño A, Ramírez-Castillo C, Cisneros L, Bosques-Padilla F, Hernández L, Gasca F, Flores-Murrieta F, Treviño S, Tapia G, Armendariz-Borunda J, Muñoz-Espinosa LE. Poo JL, et al. Hepatol Int. 2020 Sep;14(5):817-827. doi: 10.1007/s12072-020-10069-3. Epub 2020 Aug 19. Hepatol Int. 2020. PMID: 32813194 Free PMC article. Clinical Trial.
Challenges in treating liver fibrosis.
Poo JL, Muñoz LE. Poo JL, et al. Ann Hepatol. 2014 Nov-Dec;13(6):845-6. Ann Hepatol. 2014. PMID: 25332275 Free article. No abstract available.
Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C.
Bruix J, Poynard T, Colombo M, Schiff E, Burak K, Heathcote EJ, Berg T, Poo JL, Mello CB, Guenther R, Niederau C, Terg R, Bedossa P, Boparai N, Griffel LH, Burroughs M, Brass CA, Albrecht JK; EPIC3 Study Group. Bruix J, et al. Among authors: poo jl. Gastroenterology. 2011 Jun;140(7):1990-9. doi: 10.1053/j.gastro.2011.03.010. Epub 2011 Mar 17. Gastroenterology. 2011. PMID: 21419770 Clinical Trial.
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy.
Poynard T, Colombo M, Bruix J, Schiff E, Terg R, Flamm S, Moreno-Otero R, Carrilho F, Schmidt W, Berg T, McGarrity T, Heathcote EJ, Gonçales F, Diago M, Craxi A, Silva M, Bedossa P, Mukhopadhyay P, Griffel L, Burroughs M, Brass C, Albrecht J; Epic Study Group. Poynard T, et al. Gastroenterology. 2009 May;136(5):1618-28.e2. doi: 10.1053/j.gastro.2009.01.039. Epub 2009 Jan 22. Gastroenterology. 2009. PMID: 19208349 Clinical Trial.
51 results